France is currently grappling with a resurgence of lumpy skin disease (LSD) in its cattle population, with outbreaks spreading across multiple regions including eastern France and near the Spanish border. The viral disease, which is transmitted primarily through insect bites, causes painful skin lesions and lowers milk production in affected cattle, posing significant challenges for livestock farmers and trade.
Lumpy skin disease is caused by the Capripoxvirus and historically endemic to parts of Africa and the Middle East, it expanded into Southeastern Europe in 2015, reaching Asia by 2019. Its emergence in Western Europe is recent, with the first Western European outbreak reported on Sardinia, Italy, in late June 2025, followed by cases in France and Spain. France has now recorded 83 outbreaks, Italy 72, and Spain nine, according to the World Organisation for Animal Health (WOAH).
The disease predominantly affects cattle and buffalo but does not infect humans; hence it is not considered a zoonotic risk. However, LSD frequently results in substantial economic losses due to decreased milk yields, damaged hides, animal culling, and trade restrictions. For instance, countries like the United Kingdom and others have imposed bans on imports of certain raw milk cheeses from France amid the outbreaks.
Key Developments and Response Efforts
Following a sharp rise in outbreaks through July and early August 2025, French authorities implemented an extensive vaccination campaign starting mid-July. Over 220,000 cattle have been vaccinated, representing more than 90% coverage of cattle within high-risk zones around outbreaks, predominantly in the Alpine departments of Savoie, Haute-Savoie, and neighboring Ain. Despite initial success in reducing new cases by late August, the number of outbreaks has again surged, with recent cases detected in the Pyrenees-Orientales near the Spanish border.
In addition to vaccination, movement restrictions and enhanced veterinary surveillance have been imposed within 50-kilometer regulated zones around outbreak sites to curb spread. Herd culling is employed where infections are confirmed, aimed at disease containment.
Expert Perspectives and Context
Dr. Claire Moreau, a veterinary epidemiologist unaffiliated with the outbreak response, explains, “Lumpy skin disease is highly contagious among cattle, especially where populations are dense and insect vectors such as biting flies are prevalent. Vaccination is crucial but must be complemented by movement controls and vector management to be effective.” She highlights that vaccination requires approximately three weeks to establish immunity, underlining the risk of infections occurring shortly after inoculation.
Historically, lumpy skin disease’s expanding range reflects climate and ecological changes facilitating vector habitats in Europe. France’s cattle population, the largest in the EU at approximately 17 million heads, is particularly vulnerable given the density and economic reliance on dairy and beef production.
Public Health and Economic Implications
From a public health perspective, LSD poses no direct threat to humans. However, the disease significantly impacts food security and rural livelihoods due to reduced cattle productivity and income loss from export bans. The outbreaks have particularly unsettled producers in cheese-producing regions renowned for varieties like Reblochon and Beaufort, where restrictions disrupt supply chains.
Economic consequences extend from culling costs—about 1,700 cattle in France have been culled so far—to the broader market effects of export bans and consumer anxiety. These factors underscore the importance of coordinated surveillance and prompt response strategies to mitigate further losses.
Potential Limitations and Challenges
While vaccination campaigns have slowed outbreaks, the resurgence in cases underscores challenges in controlling insect-borne diseases. Complete eradication requires controlling vector populations and managing environmental factors which can be difficult in regions with wild or dispersed cattle herds. Moreover, vaccine coverage gaps or infections prior to immunity establishment continue to allow localized spread.
Some experts caution that reliance solely on vaccination without integrated pest management and strict biosecurity might prolong outbreaks. Continuous monitoring and research into vaccine efficacy against evolving viral strains remain priorities. The dynamic geopolitical landscape of livestock trade in Europe also complicates control measures.
Practical Implications for Readers
For stakeholders and general readers, this situation emphasizes the interconnectedness of animal health, economics, and public health. While consumers face minimal direct risk, supporting sustainable agricultural practices, understanding trade impacts, and remaining informed about regional livestock health are relevant. Farmers and local authorities must continue vigilant vaccination, quarantine, and biosecurity measures to protect herds and livelihoods.
Medical Disclaimer
This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.